U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 43 results

Status:
US Approved Rx (2004)
First approved in 2004

Class (Stereo):
CHEMICAL (ABSOLUTE)



Rifaximin is a structural analog of rifampin and a non-systemic, gastrointestinal site-specific antibiotic. Rifaximin acts by inhibiting bacterial ribonucleic acid (RNA) synthesis and contributes to restore intestinal microflora imbalance. It is FDA ...
Status:
US Approved Rx (2003)
First approved in 1983

Class (Stereo):
CHEMICAL (ABSOLUTE)



Cefuroxime is a semisynthetic, broad-spectrum, cephalosporin antibiotic. Cefuroxime is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Cefuroxime has activity in the presence of some beta-lactamases, both penicillinases...
Status:
US Approved Rx (2010)
First approved in 1973

Class (Stereo):
CHEMICAL (ACHIRAL)



Trimethoprim (TMP) is an antibiotic is used for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: Escherichia coli, Proteus mirabilis, Klebsiella pneumoniae, Enterobacte...
Status:
US Approved Rx (2006)
First approved in 1973

Class (Stereo):
CHEMICAL (ABSOLUTE)



Cefazolin is a semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, cefazolin in...
Status:
US Approved Rx (2010)
First approved in 1971

Class (Stereo):
CHEMICAL (ABSOLUTE)



Cephalexin is a semisynthetic cephalosporin antibiotic intended for oral administration. In vitro tests demonstrate that the cephalosporins are bactericidal because of their inhibition of cell-wall synthesis. Cephalexin has been shown to be active ag...
Status:
US Approved Rx (2022)
First approved in 1968

Class (Stereo):
CHEMICAL (ABSOLUTE)



Dicloxacillin sodium USP is a semisynthetic antibiotic substance which resists destruction by the enzyme penicillinase (beta-lactamase). It is monosodium (2S,5R,6R)-6-[3-(2,6-dichlorophenyl)-5-methyl-4- isoxazolecarboxamido]-3,3-dimethyl-7-oxo-4-thia...
Status:
US Approved Rx (1964)
First approved in 1964

Class (Stereo):
CHEMICAL (ABSOLUTE)



Lincomycin (LINCOCIN®) is an antibiotic produced by Streptomyces lincolnensis (Streptomycetaceae family). It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections. Lincomycin (LINCOCIN®) inhibits protein...
Status:
US Approved Rx (2009)
First approved in 1963

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ampicillin is a penicillin beta-lactam antibiotic. The following gram-negative and gram-positive bacteria have been shown in in vitro studies to be susceptible to ampicillin: Hemolytic and nonhemolytic streptococci, Streptococcus pneumoniae, Nonpenic...
Status:
US Approved Rx (2012)
First approved in 1962

Class (Stereo):
CHEMICAL (ABSOLUTE)



Oxacillin is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name "penicillin" can either refer to several variants of penicillin available, or to the grou...
Status:
US Approved Rx (1972)
First approved in 1952

Class (Stereo):
CHEMICAL (ABSOLUTE)



Erythromycin cyclocarbonate (Davercin) is a first generation semi-synthetic erythromycin. It is active against Gram-positive and some Gram-negative microorganisms. Davercin shows comparable or better in vitro potency, low host toxicity and improved p...